Tumor Necrosis Factor Receptor Superfamily Member 18 Market - Global Outlook and Forecast 2021-2027

Code: RW00014560217
Market Monitor Global
Oct-2021
Life Sciences
109 Pages

This report contains market size and forecasts of Tumor Necrosis Factor Receptor Superfamily Member 18 in global, including the following market information:
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Tumor Necrosis Factor Receptor Superfamily Member 18 companies in 2020 (%)
The global Tumor Necrosis Factor Receptor Superfamily Member 18 market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tumor Necrosis Factor Receptor Superfamily Member 18 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segment Percentages, By Type, 2020 (%)
AMG-228
BMS-986156
FPA-154
GWN-323
INCAGN-1876
Others

Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segment Percentages, By Application, 2020 (%)
Melanoma
Non-Small Cell Lung Cancer
Gastric Cancer
Blood Cancer
Others

Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 revenues share in global market, 2020 (%)
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ablynx NV
Amgen Inc
Apogenix GmbH
Bristol-Myers Squibb Company
Five Prime Therapeutics Inc
Incyte Corp
MedImmune LLC
Merck & Co Inc
Novartis AG
OncoMed Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Overall Market Size
2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size: 2021 VS 2027
2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players in Global Market
3.2 Top Global Tumor Necrosis Factor Receptor Superfamily Member 18 Companies Ranked by Revenue
3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Companies
3.4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Companies
3.5 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tumor Necrosis Factor Receptor Superfamily Member 18 Players in Global Market
3.8.1 List of Global Tier 1 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies
3.8.2 List of Global Tier 2 and Tier 3 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Markets, 2021 & 2027
4.1.2 AMG-228
4.1.3 BMS-986156
4.1.4 FPA-154
4.1.5 GWN-323
4.1.6 INCAGN-1876
4.1.7 Others
4.2 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue & Forecasts
4.2.1 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2021
4.2.2 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2022-2027
4.2.3 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2016-2027
4.3 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales & Forecasts
4.3.1 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2021
4.3.2 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2022-2027
4.3.3 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2016-2027
4.4 By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2021 & 2027
5.1.2 Melanoma
5.1.3 Non-Small Cell Lung Cancer
5.1.4 Gastric Cancer
5.1.5 Blood Cancer
5.1.6 Others
5.2 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue & Forecasts
5.2.1 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2021
5.2.2 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2022-2027
5.2.3 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2016-2027
5.3 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales & Forecasts
5.3.1 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2021
5.3.2 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2022-2027
5.3.3 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2016-2027
5.4 By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2021 & 2027
6.2 By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue & Forecasts
6.2.1 By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2021
6.2.2 By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2022-2027
6.2.3 By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2016-2027
6.3 By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales & Forecasts
6.3.1 By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2021
6.3.2 By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2022-2027
6.3.3 By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2027
6.4.2 By Country - North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2027
6.4.3 US Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.4.4 Canada Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.4.5 Mexico Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2027
6.5.2 By Country - Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2027
6.5.3 Germany Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.5.4 France Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.5.5 U.K. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.5.6 Italy Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.5.7 Russia Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.5.8 Nordic Countries Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.5.9 Benelux Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2027
6.6.2 By Region - Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2027
6.6.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.6.4 Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.6.5 South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.6.6 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.6.7 India Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2027
6.7.2 By Country - South America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2027
6.7.3 Brazil Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.7.4 Argentina Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2027
6.8.3 Turkey Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.8.4 Israel Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.8.5 Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
6.8.6 UAE Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Ablynx NV
7.1.1 Ablynx NV Corporate Summary
7.1.2 Ablynx NV Business Overview
7.1.3 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.1.4 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.1.5 Ablynx NV Key News
7.2 Amgen Inc
7.2.1 Amgen Inc Corporate Summary
7.2.2 Amgen Inc Business Overview
7.2.3 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.2.4 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.2.5 Amgen Inc Key News
7.3 Apogenix GmbH
7.3.1 Apogenix GmbH Corporate Summary
7.3.2 Apogenix GmbH Business Overview
7.3.3 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.3.4 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.3.5 Apogenix GmbH Key News
7.4 Bristol-Myers Squibb Company
7.4.1 Bristol-Myers Squibb Company Corporate Summary
7.4.2 Bristol-Myers Squibb Company Business Overview
7.4.3 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.4.5 Bristol-Myers Squibb Company Key News
7.5 Five Prime Therapeutics Inc
7.5.1 Five Prime Therapeutics Inc Corporate Summary
7.5.2 Five Prime Therapeutics Inc Business Overview
7.5.3 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.5.4 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.5.5 Five Prime Therapeutics Inc Key News
7.6 Incyte Corp
7.6.1 Incyte Corp Corporate Summary
7.6.2 Incyte Corp Business Overview
7.6.3 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.6.4 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.6.5 Incyte Corp Key News
7.7 MedImmune LLC
7.7.1 MedImmune LLC Corporate Summary
7.7.2 MedImmune LLC Business Overview
7.7.3 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.4.4 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.7.5 MedImmune LLC Key News
7.8 Merck & Co Inc
7.8.1 Merck & Co Inc Corporate Summary
7.8.2 Merck & Co Inc Business Overview
7.8.3 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.8.4 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.8.5 Merck & Co Inc Key News
7.9 Novartis AG
7.9.1 Novartis AG Corporate Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.9.4 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.9.5 Novartis AG Key News
7.10 OncoMed Pharmaceuticals Inc
7.10.1 OncoMed Pharmaceuticals Inc Corporate Summary
7.10.2 OncoMed Pharmaceuticals Inc Business Overview
7.10.3 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.10.4 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.10.5 OncoMed Pharmaceuticals Inc Key News
7.11 Regeneron Pharmaceuticals Inc
7.11.1 Regeneron Pharmaceuticals Inc Corporate Summary
7.11.2 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Business Overview
7.11.3 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.11.4 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2016-2021)
7.11.5 Regeneron Pharmaceuticals Inc Key News
8 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity, Analysis
8.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity, 2016-2027
8.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity of Key Manufacturers in Global Market
8.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tumor Necrosis Factor Receptor Superfamily Member 18 Supply Chain Analysis
10.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Value Chain
10.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Upstream Market
10.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Tumor Necrosis Factor Receptor Superfamily Member 18 in Global Market
Table 2. Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Companies, 2016-2021
Table 5. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
Table 9. List of Global Tier 1 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Ablynx NV
Amgen Inc
Apogenix GmbH
Bristol-Myers Squibb Company
Five Prime Therapeutics Inc
Incyte Corp
MedImmune LLC
Merck & Co Inc
Novartis AG
OncoMed Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE